Literature DB >> 26755796

Relationships between Personal Measurements of 'Total' Dust, Respirable, Thoracic, and Inhalable Aerosol Fractions in the Cement Production Industry.

Hilde P Notø1, Karl-Christian Nordby2, Wijnand Eduard3.   

Abstract

AIMS: The aims of this study were to examine the relationships and establish conversion factors between 'total' dust, respirable, thoracic, and inhalable aerosol fractions measured by parallel personal sampling on workers from the production departments of cement plants. 'Total' dust in this study refers to aerosol sampled by the closed face 37-mm Millipore filter cassette.
METHODS: Side-by-side personal measurements of 'total' dust and respirable, thoracic, and inhalable aerosol fractions were performed on workers in 17 European and Turkish cement plants. Simple linear and mixed model regressions were used to model the associations between the samplers.
RESULTS: The total number of personal samples collected on 141 workers was 512. Of these 8.4% were excluded leaving 469 for statistical analysis. The different aerosol fractions contained from 90 to 130 measurements and-side-by side measurements of all four aerosol fractions were collected on 72 workers.The median ratios between observed results of the respirable, 'total' dust, and inhalable fractions relative to the thoracic aerosol fractions were 0.51, 2.4, and 5.9 respectively. The ratios between the samplers were not constant over the measured concentration range and were best described by regression models. Job type, position of samplers on left or right shoulder and plant had no substantial effect on the ratios.
CONCLUSIONS: The ratios between aerosol fractions changed with different air concentrations. Conversion models for estimation of the fractions were established. These models explained a high proportion of the variance (74-91%) indicating that they are useful for the estimation of concentrations based on measurements of a different aerosol fraction. The calculated uncertainties at most observed concentrations were below 30% which is acceptable for comparison with limit values (EN 482, 2012). The cement industry will therefore be able to predict the health related aerosol fractions from their former or future measurements of one of the fractions.
© The Author 2016. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Keywords:  cement dust; comparative field study; health-relevant particle size fraction; personal sampling; side-by-side measurements

Mesh:

Substances:

Year:  2016        PMID: 26755796     DOI: 10.1093/annhyg/mev093

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  5 in total

1.  Thoracic dust exposure is associated with lung function decline in cement production workers.

Authors:  Karl-Christian Nordby; Hilde Notø; Wijnand Eduard; Marit Skogstad; Anne Kristin Fell; Yngvar Thomassen; Øivind Skare; Antonio Bergamaschi; Antonio Pietroiusti; Rolf Abderhalden; Johny Kongerud; Helge Kjuus
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

Review 2.  Association between exposure in the cement production industry and non-malignant respiratory effects: a systematic review.

Authors:  Anne Kristin Møller Fell; Karl Christian Nordby
Journal:  BMJ Open       Date:  2017-04-24       Impact factor: 2.692

Review 3.  Review of Workplace Based Aerosol Sampler Comparison Studies, 2004-2020.

Authors:  James Hanlon; Karen S Galea; Steven Verpaele
Journal:  Int J Environ Res Public Health       Date:  2021-06-25       Impact factor: 3.390

4.  Total and respirable dust exposures among carpenters and demolition workers during indoor work in Denmark.

Authors:  Lilli Kirkeskov; Dorte Jessing Agerby Hanskov; Charlotte Brauer
Journal:  J Occup Med Toxicol       Date:  2016-09-20       Impact factor: 2.646

5.  Estimating Respirable Dust Exposure from Inhalable Dust Exposure.

Authors:  Cornelia Wippich; Jörg Rissler; Dorothea Koppisch; Dietmar Breuer
Journal:  Ann Work Expo Health       Date:  2020-04-30       Impact factor: 2.179

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.